Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$0.32 - $15.6 $9,593 - $467,672
29,979 Added 1328.86%
32,235 $10,000
Q2 2022

Aug 15, 2022

SELL
$0.56 - $1.25 $1,872 - $4,178
-3,343 Reduced 59.71%
2,256 $1,000
Q1 2022

May 12, 2022

BUY
$0.86 - $1.86 $4,815 - $10,414
5,599 New
5,599 $7,000
Q4 2021

Feb 14, 2022

SELL
$1.64 - $3.13 $3,020 - $5,765
-1,842 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.67 - $5.09 $4,717 - $8,994
1,767 Added 2356.0%
1,842 $5,000
Q2 2021

Aug 16, 2021

BUY
$2.02 - $7.64 $151 - $573
75 New
75 $0

About ReShape Lifesciences Inc.


  • Ticker RSLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,559,400
  • Market Cap $130M
  • Description
  • ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical sta...
More about RSLS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.